Ligand Pharmaceuticals Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$63,693	$51,722	$59,666	$115,461
Gross Profit	60,479	49,647	85,654	90,641
EBITDA	72,401	-14,296	66,404	149,232
EBIT	64,304	-22,512	56,780	141,137
Net Income	48,508	-13,345	44,784	117,273
Net Change In Cash	63,693	51,722	59,666	115,461
Free Cash Flow	23,992	48,463	45,835	13,075
Cash	1,006,702	115,077	174,927	139,376
Basic Shares	21,837	19,883	21,138	20,170

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$268,087	$167,133	$131,314	$196,245
Gross Profit	261,499	156,059	96,265	143,418
EBITDA	192,735	40,794	100,837	81,204
EBIT	158,960	5,555	64,316	37,810
Net Income	124,453	-4,032	52,154	-33,361
Net Change In Cash	268,087	167,133	131,314	196,245
Free Cash Flow	48,907	77,407	-4,272	119,927
Cash	174,927	72,307	22,954	45,006
Basic Shares	20,294	18,290	17,757	16,868